版本:
中国

BRIEF-Biostage Inc's common stock would be subject to delisting from NASDAQ unless co timely requests a hearing before NASDAQ hearings panel

May 22 Biostage Inc:

* Biostage Inc - company's common stock would be subject to delisting from NASDAQ unless company timely requests a hearing before NASDAQ hearings panel

* Biostage Inc - company plans to timely request a hearing before panel

* Biostage- delisting based on continued non-compliance with bid price rule as of May 17, 2017 & non-compliance with minimum $2.5 million stockholders equity requirement Source text: (bit.ly/2qLNidd) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐